The impact of atopic dermatitis on sexual health.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
11
05
2018
accepted:
26
07
2018
pubmed:
31
8
2018
medline:
7
6
2019
entrez:
31
8
2018
Statut:
ppublish
Résumé
Sexual health is frequently affected by chronic diseases but has been poorly investigated in patients with atopic dermatitis (AD). To evaluate the risk factors for impaired sexual desire and its relationship with the burden and quality of life of patients with AD. A multicentre prospective transversal study in patients with AD. Socio-demographic and clinical data were obtained from all patients using a specifically developed questionnaire. In addition, patients were asked to answer validated scales, that is ABS-A, DLQI, SF-12 and EQ-5D. A total of 1024 patients participated in the study. Severity of AD, sites involved and treatment type was found to negatively impact the sexual desire of patients and their partners. In addition, the involvement of the genital and visible areas was associated with a higher burden and more significant alterations in quality of life. The results of this study are substantial and clearly demonstrate the deep impact of AD on sexual health, its relationship with disease-related burden and alterations to quality of life. Psychosociological as well as neurosensory phenomena could help to understand these data.
Sections du résumé
BACKGROUND
BACKGROUND
Sexual health is frequently affected by chronic diseases but has been poorly investigated in patients with atopic dermatitis (AD).
OBJECTIVE
OBJECTIVE
To evaluate the risk factors for impaired sexual desire and its relationship with the burden and quality of life of patients with AD.
METHODS
METHODS
A multicentre prospective transversal study in patients with AD. Socio-demographic and clinical data were obtained from all patients using a specifically developed questionnaire. In addition, patients were asked to answer validated scales, that is ABS-A, DLQI, SF-12 and EQ-5D.
RESULTS
RESULTS
A total of 1024 patients participated in the study. Severity of AD, sites involved and treatment type was found to negatively impact the sexual desire of patients and their partners. In addition, the involvement of the genital and visible areas was associated with a higher burden and more significant alterations in quality of life.
CONCLUSIONS
CONCLUSIONS
The results of this study are substantial and clearly demonstrate the deep impact of AD on sexual health, its relationship with disease-related burden and alterations to quality of life. Psychosociological as well as neurosensory phenomena could help to understand these data.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
428-432Subventions
Organisme : Sanofi
Informations de copyright
© 2018 European Academy of Dermatology and Venereology.